James N Kochenderfer Selected Research

James N Kochenderfer Research Topics

27	Neoplasms (Cancer) 11/2021 - 12/2006
9	Multiple Myeloma 01/2021 - 04/2013
6	Lymphoma (Lymphomas) 01/2020 - 11/2010
5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 02/2015
5	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 04/2013
5	Leukemia 12/2017 - 09/2009
3	Infections 12/2021 - 12/2017
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 03/2016
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019 - 02/2015
2	Cytokine Release Syndrome 01/2022 - 01/2016
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 01/2018
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2018 - 12/2013
2	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2016 - 03/2016
1	cell-associated neurotoxicity 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Cytopenia 01/2022
1	Neutropenia 12/2021
1	Fever (Fevers) 12/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Brain Edema (Cerebral Edema) 01/2020
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 12/2017
1	Neoplasm Metastasis (Metastasis) 04/2016
1	Pigmented Villonodular Synovitis 04/2016
1	Tumor Lysis Syndrome 12/2013
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2013
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2010
1	Residual Neoplasm 07/2007
1	Melanoma (Melanoma, Malignant) 12/2006

32	Chimeric Antigen ReceptorsIBA 01/2022 - 09/2009
9	AntigensIBA 12/2021 - 07/2007
6	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022 - 04/2013
6	CytokinesIBA 01/2020 - 03/2012
5	B-Cell Maturation AntigenIBA 01/2020 - 04/2013
3	axicabtagene ciloleucelIBA 01/2022 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 11/2021 - 12/2006
3	Interleukin-2 (IL2)IBA 08/2007 - 12/2006
3	VaccinesIBA 08/2007 - 12/2006
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 01/2020
2	Interleukin-15 (Interleukin 15)IBA 01/2018 - 06/2017
2	EpitopesIBA 07/2007 - 12/2006
2	Peptides (Polypeptides)IBA 07/2007 - 12/2006
1	tocilizumab (atlizumab)FDA Link 12/2021
1	remdesivirIBA 10/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	idecabtagene vicleucelIBA 01/2019
1	LigandsIBA 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	tisagenlecleucelIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2017
1	Therapeutic UsesIBA 12/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2016
1	Interleukin-6 (Interleukin 6)IBA 03/2016
1	InterleukinsIBA 03/2016
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2016
1	crisamicin AIBA 01/2016
1	Biological ProductsIBA 02/2015
1	CD19 AntigensIBA 11/2010
1	AutoantigensIBA 11/2010
1	Trastuzumab (Herceptin)FDA Link 11/2009
1	Muromonab-CD3 (Muromonab CD3)FDA Link 09/2009
1	Monophenol Monooxygenase (Tyrosinase)IBA 12/2006
1	CPG-oligonucleotideIBA 12/2006
1	OligodeoxyribonucleotidesIBA 12/2006

15	Therapeutics 01/2022 - 11/2010
6	Drug Therapy (Chemotherapy) 12/2021 - 11/2010
6	Immunotherapy 01/2019 - 11/2011
3	Hematopoietic Stem Cell Transplantation 04/2016 - 12/2013
2	Aftercare (After-Treatment) 01/2018 - 12/2013
2	Stem Cell Transplantation 06/2017 - 07/2007
1	Resuscitation 01/2020
1	Antibiotic Prophylaxis 12/2017
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2011